Design of 1-piperazinyl-4-arylphthalazines as potent Smoothened antagonists-Reference-Cited by-同舟云学术

Design of 1-piperazinyl-4-arylphthalazines as potent Smoothened antagonists

Published:2010-06 Issue:12 Volume:20 Page:3618-3622
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Lucas Brian S.,Aaron Wade,An Songzhu,Austin Richard J.,Brown Matthew,Chan Hon,Chong Angela,Hungate Randall,Huang Tom,Jiang Ben,Johnson Michael G.,Kaizerman Jacob A.,Lee Gary,McMinn Dustin L.,Orf Jessica,Powers Jay P.,Rong Minqing,Toteva Maria M.,Uyeda Craig,Wickramasinghe Dineli,Xu Guifen,Ye Qiuping,Zhong Wendy

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference28 articles.

1. Hedgehog signaling in animal development: paradigms and principles

2. Targeting the Hedgehog pathway in cancer

3. The Hedgehog Response Network: Sensors, Switches, and Routers

4. Basal cell carcinomas: attack of the hedgehog

5. Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medicinal chemistry perspectives on the development of piperazine-containing HIV-1 inhibitors;Bioorganic & Medicinal Chemistry;2024-02

2. Pyridazines and Their Benzo Derivatives;Comprehensive Heterocyclic Chemistry IV;2022

3. Medulloblastoma drugs in development: Current leads, trials and drawbacks;European Journal of Medicinal Chemistry;2021-04

4. Phthalazinone Scaffold: Emerging Tool in the Development of Target Based Novel Anticancer Agents;Anti-Cancer Agents in Medicinal Chemistry;2020-11-23

5. State of the art of Smo antagonists for cancer therapy: advances in the target receptor and new ligand structures;Future Medicinal Chemistry;2019-03